Topics

Opinion: PhRMA’s talking points shouldn’t derail the Pelosi drug pricing bill

04:35 EDT 11 Oct 2019 | STAT

We need serious reform of both pricing and insurance coverage of prescription drugs. There will be tradeoffs, but if you want to know what they are, don't read PhRMA's talking…

Original Article: Opinion: PhRMA’s talking points shouldn’t derail the Pelosi drug pricing bill

NEXT ARTICLE

More From BioPortfolio on "Opinion: PhRMA’s talking points shouldn’t derail the Pelosi drug pricing bill"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...